FDAFDA PCAC reviews BPC-157, KPV, TB-500, MOTS-c (Jul 23) and DSIP, Semax, Epitalon (Jul 24, 2026) for 503A compounding eligibilityUPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORY12 peptides removed from FDA Category 2 (Apr 23, 2026) — removal is not approval; all remain pending PCAC reviewREGULATORYNo formal FDA reclassification published — no restricted peptide is legal to compound; 5 more peptides go to PCAC before Feb 2027RESEARCHA Real-world Study of Treatment Retention and Adherence to Secukinumab in Patients With Plaque Psoriasis (PsO) With or Without Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) Co-therapy [NCT07881783]RESEARCHStudy to Evaluate the Dose-Dependent Effect of Tirzepatide on Gastric Emptying in Adult Patients With Type 1 Diabetes [NCT07951658]RESEARCHA Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity [NCT06037252]RESEARCHA Study to Learn About the Study Medicine Called Rimegepant in Adults When Used for the Prevention of Chronic Migraine [NCT07729462]RESEARCHHypersensitivity to Amylin in Post-Traumatic Headache [NCT07340775]RESEARCHEffects of Tirzepatide on Corneal Nerve Morphology and Other Ocular Parameters in Adults With Obesity [NCT07950371]NEWSSTAT+: Peptide market poised to explode with new Hims and Noom launchesRESEARCHAlleviating Carbohydrate Counting for Patients With Type-1 Diabetes Using a Closed Loop System With Weekly Subcutaneous Semaglutide [NCT06387199]RESEARCHWeight Trajectories and Predictive Factors After Semaglutide in Patients With Grade 3 and Complicated Obesity [NCT07423481]RESEARCHSEMAFORCRANIO : Multicenter, Double-blind, Parallel, Randomized Controlled Trial of the Efficacy of Semaglutide in Hypothalamic Obesity Secondary to Craniopharyngioma in Children Aged 12 to 17 Years [NCT07845994]FDAFDA PCAC reviews BPC-157, KPV, TB-500, MOTS-c (Jul 23) and DSIP, Semax, Epitalon (Jul 24, 2026) for 503A compounding eligibilityUPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORY12 peptides removed from FDA Category 2 (Apr 23, 2026) — removal is not approval; all remain pending PCAC reviewREGULATORYNo formal FDA reclassification published — no restricted peptide is legal to compound; 5 more peptides go to PCAC before Feb 2027RESEARCHA Real-world Study of Treatment Retention and Adherence to Secukinumab in Patients With Plaque Psoriasis (PsO) With or Without Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) Co-therapy [NCT07881783]RESEARCHStudy to Evaluate the Dose-Dependent Effect of Tirzepatide on Gastric Emptying in Adult Patients With Type 1 Diabetes [NCT07951658]RESEARCHA Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity [NCT06037252]RESEARCHA Study to Learn About the Study Medicine Called Rimegepant in Adults When Used for the Prevention of Chronic Migraine [NCT07729462]RESEARCHHypersensitivity to Amylin in Post-Traumatic Headache [NCT07340775]RESEARCHEffects of Tirzepatide on Corneal Nerve Morphology and Other Ocular Parameters in Adults With Obesity [NCT07950371]NEWSSTAT+: Peptide market poised to explode with new Hims and Noom launchesRESEARCHAlleviating Carbohydrate Counting for Patients With Type-1 Diabetes Using a Closed Loop System With Weekly Subcutaneous Semaglutide [NCT06387199]RESEARCHWeight Trajectories and Predictive Factors After Semaglutide in Patients With Grade 3 and Complicated Obesity [NCT07423481]RESEARCHSEMAFORCRANIO : Multicenter, Double-blind, Parallel, Randomized Controlled Trial of the Efficacy of Semaglutide in Hypothalamic Obesity Secondary to Craniopharyngioma in Children Aged 12 to 17 Years [NCT07845994]

Solo a fini di ricerca. Disposizione completa →

Contatti

Ogni persona e organizzazione che sta modellando il paesaggio dei peptidi — ricercatori che pubblicano la scienza, clinici che lo applicano, influencer che l'amplificano e aziende farmaceutiche che lo portano al mercato.

18 risultati

PS
Predrag Sikiric
Researcher
University of Zagreb

Predrag Sikiric is a researcher focusing on the therapeutic applications of peptides, particularly BPC-157.

AG
Allan Goldstein
Researcher
George Washington University

Allan L. Goldstein is an American molecular biologist known for his research on thymosin alpha-1 and thymosin beta-4, focusing on their roles in various biological processes including immunology, neurogenesis, and tissue repair.

Ana Maria Cuervo
Ana Maria Cuervo
Researcher
Albert Einstein College of Medicine

Ana Maria Cuervo is a Spanish-American physician and researcher specializing in cell biology at the Albert Einstein College of Medicine, where she investigates autophagy's role in aging and age-related diseases.

Brian Kennedy
Brian Kennedy
Researcher
National University of Singapore

Brian K. Kennedy is an American biologist known for his research on aging and metabolism, including studies on NAD+ and interventions to slow aging in humans.

CB
Cyril Bowers
Researcher
Tulane University

Cyril Y. Bowers, M.D., is an emeritus professor of medicine at Tulane University with extensive research in endocrinology and metabolism, focusing on growth hormone regulation and the effects of sex steroids.

David Sabatini
David Sabatini
Researcher
MIT

David M. Sabatini is an American cell biologist known for his work on the mTOR pathway and its regulation by nutrients, contributing significantly to the understanding of cellular metabolism and aging.

JA
Johan Auwerx
Researcher
EPFL

Johan Auwerx is a Belgian biologist and professor at EPFL, focusing on cellular metabolism and mitochondrial function.

Kent Holtorf
Kent Holtorf
Researcher
Holtorf Medical Group

Kent Holtorf is an American physician and entrepreneur based in Los Angeles, founder of the Holtorf Medical Group which offers treatments for various conditions using alternative therapies. He is known for his work on hormone therapy and peptide-based treatments.

Loren Cordain
Loren Cordain
Researcher
Colorado State University

Loren Cordain is an American scientist specializing in nutrition and exercise physiology, known for advocating the Paleolithic diet.

MC
Michael Chorev
Researcher
Harvard Medical School

Michael Chorev is a researcher focusing on peptide chemistry, particularly the design and synthesis of novel peptide analogues. His work includes conformational analysis and biological activity studies of these compounds.

Michael Zasloff
Michael Zasloff
Researcher
Georgetown University

Michael Zasloff is an immunologist and biotechnology entrepreneur known for discovering antimicrobial peptides in amphibians, including magainins, and developing shark-derived compound squalamine. He is currently a professor at Georgetown University School of Medicine and Scientific Director of the MedStar Georgetown Transplant Institute.

NB
Nir Barzilai
Researcher
Albert Einstein College of Medicine

Nir Barzilai is an Israeli geneticist and longevity researcher known for his work on the genetics of human longevity and the role of insulin-like growth factor 1 (IGF-1) in aging.

PC
Pinchas Cohen
Researcher
USC
RD
Richard DiMarchi
Researcher
Indiana University

Richard DiMarchi is an American pharmaceutical chemist and professor at Indiana University, known for his research on GLP-1 and semaglutide. He previously served as a vice president at Eli Lilly and Company.

SM
Svetlana Morozova
Researcher
Institute of Biomedical Chemistry

Svetlana Morozova is a researcher with expertise in the persistence length of α-helical poly-L-lysine. She has published work relevant to the peptide field, particularly focusing on semax and selank.

VH
Victor Hruby
Researcher
University of Arizona

Victor Hruby is a researcher known for his work in peptide chemistry, including the development of melanotan and PT-141.

VK
Vladimir Khavinson
Researcher
St. Petersburg Institute of Bioregulation

Vladimir Khavinson was a Russian gerontologist and professor known for his research on peptide bioregulators, including epithalon.

WM
William Mitch
Researcher
Baylor College of Medicine

William Mitch is a researcher focusing on peptide therapy and its implications in longevity, muscle health, and chronic diseases such as kidney disease and diabetes.